Literature DB >> 201380

Adriamycin therapy in American patients with hepatocellular carcinoma.

D C Ihde, R C Kane, M H Cohen, K R McIntire, J D Minna.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 201380

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN： 0361-5960


× No keyword cloud information.
  9 in total

1.  Intra-arterial administration of epirubicin in the treatment of nonresectable hepatocellular carcinoma. Epirubicin Study Group for Hepatocellular Carcinoma.

Authors: 
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

2.  Phase II trial of nolatrexed dihydrochloride [Thymitaq, AG 337] in patients with advanced hepatocellular carcinoma.

Authors:  Minaxi Jhawer; Lee Rosen; Janet Dancey; Howard Hochster; Solomon Hamburg; Margaret Tempero; Neil Clendeninn; Sridhar Mani
Journal:  Invest New Drugs       Date:  2006-09-07       Impact factor: 3.850

3.  Chemotherapy with etoposide, doxorubicin, cisplatin, 5-fluorouracil, and leucovorin for patients with advanced hepatocellular carcinoma.

Authors:  Jeng-Nian Yuan; Yee Chao; Wei-Ping Lee; Chung-Pin Li; Rheun-Chuan Lee; Full-Young Chang; Sang-Hue Yen; Shou-Dong Lee; Jacqueline Whang-Peng
Journal:  Med Oncol       Date:  2007-10-06       Impact factor: 3.064

4.  Right trisegmentectomy for hepatic neoplasms.

Authors:  T E Starzl; L J Koep; R Weil; J R Lilly; C W Putnam; J A Aldrete
Journal:  Surg Gynecol Obstet       Date:  1980-02

5.  A multi-institutional phase II study of the efficacy and tolerability of lapatinib in patients with advanced hepatocellular carcinomas.

Authors:  Tanios Bekaii-Saab; Joseph Markowitz; Nichole Prescott; Wolfgang Sadee; Nyla Heerema; Lai Wei; Zunyan Dai; Audrey Papp; Angela Campbell; Kristy Culler; Catherine Balint; Bert O'Neil; Ruey-Min Lee; Mark Zalupski; Janet Dancey; Helen Chen; Michael Grever; Charis Eng; Miguel Villalona-Calero
Journal:  Clin Cancer Res       Date:  2009-09-08       Impact factor: 12.531

6.  No synergistic activity of epirubicin and interferon-alpha 2b in the treatment of hepatocellular carcinoma.

Authors:  C Bokemeyer; B Kynast; A Harstrick; E Laage; E Schmoll; P von Wussow; H J Schmoll
Journal:  Cancer Chemother Pharmacol       Date:  1995       Impact factor: 3.333

7.  Current management of advanced hepatocellular carcinoma.

Authors:  Ghassan K Abou-Alfa; Fidel-David Huitzil-Melendez; Eileen M O'Reilly; Leonard B Saltz
Journal:  Gastrointest Cancer Res       Date:  2008-03

Review 8.  Molecular targeted therapy in hepatocellular carcinoma: from biology to clinical practice and future.

Authors:  Anuj Patel; Weijing Sun
Journal:  Curr Treat Options Oncol       Date:  2014-09

9.  [Approaches to a selective chemotherapy of hepatocellular carcinoma (author's transl)].

Authors:  J Pausch; A Holstege; D Keppler; W Gerok
Journal:  Klin Wochenschr       Date:  1981-06-15
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.